Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF

Boots, R. J.; Paterson, D. L.; Allworth, A. M.; Faoagali, J. L.
November 1999
Thorax;Nov1999, p1047
Academic Journal
No abstract available.


Related Articles

  • Successfully treated invasive pulmonary aspergillosis in a patient with diabetic ketoacidosis. Kumagai, Ryo; Ohara, Gen; Sato, Shinya; Miyazaki, Kunihiko; Kagohashi, Katsunori; Kurishima, Koichi; Satoh, Hiroaki // Central European Journal of Medicine;Oct2013, Vol. 8 Issue 5, p685 

    We report herein a case of diabetic ketoacidosis associated with invasive aspergillosis that was successfully treated with liposomal amphotericin-B (L-AMB). Early intervention after confirming the diagnosis of invasive pulmonary aspergillosis is very important, and initiating early treatment...

  • Combination Therapy for Aspergillosis: Is It Needed, and Which Combination? Wheat, L. Joseph // Journal of Infectious Diseases;6/15/2003, Vol. 187 Issue 12, p1831 

    Editorial. Focuses on the treatment of aspergillosis. Usage of drug amphotericin B in treating aspergillosis; Effectiveness of various combination of drugs in treatment of aspergillosis.

  • An Unusual Case of Pulmonary Invasive Aspergillosis and Aspergilloma Cured with Voriconazole in a Patient with Cystic Fibrosis. Chow, Laura; Brown, Neil E.; Kunimoto, Dennis // Clinical Infectious Diseases;11/1/2002, Vol. 35 Issue 9, pe106 

    The development of pulmonary aspergilloma and invasive aspergillosis is a rare complication of cystic fibrosis. We describe a 29-year-old patient with cystic fibrosis who had invasive pulmonary aspergillosis that was not cured by amphotericin B, liposomal amphotericin B, or itraconazole. This...

  • Liposomal Amphotericin B in the Treatment of Fungal Infections. Lopez-Berestein, Gabriel // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p130 

    Editorial. Discusses the use of amphotericin B, a polyene antibiotic, in the treatment of systemic fungal infections. Effectiveness of the agent for the treatment of leishmaniasis; Mechanism of action of amphotericin B; Definition of the term liposomes; Therapeutic use of liposomal amphotericin B.

  • Amphotericin B liposomal.  // Reactions Weekly;1/26/2008, Issue 1186, p8 

    The article describes the case of four patients who developed hyperphosphataemia during treatment with amphotericin B liposomal for invasive mycoses. An 11-year-old boy, who had Aspergillosis fumigatis, received amphotericin B liposomal and developed hyperphosphataemia, which led to drug...

  • Amphotericin B liposomal.  // Reactions Weekly;Apr2015, Vol. 1548 Issue 1, p27 

    The article presents a case study of a 46-year old woman who developed therapy failure of invasive aspergillosis (IA) after receiving treatment with amphotericin B liposomal.

  • Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. Hauggaard, A.; Ellis, M.; Ekelund, L. // Acta Radiologica;May2002, Vol. 43 Issue 3, p292 

    Purpose: We report the chest radiographic and CT findings in 21 immunocompromised patients with invasive pulmonary aspergillosis (IPA) and describe the outcome when the early diagnosis was linked to treatment with liposomal amphotericin B. Material and Methods: Chest...

  • Cerebral aspergillosis in the critically ill: two cases of successful medical treatment. Ehrmann, Stephan; Bastides, Frédéric; Gissot, Valérie; Mercier, Emmanuelle; Magro, Pascal; Bailly, Eric; Legras, Annick; Bastides, Frédéric; Gissot, Valérie // Intensive Care Medicine;May2005, Vol. 31 Issue 5, p738 

    Objective: Invasive aspergillosis is associated with a poor prognosis, especially in critically ill patients with cerebral involvement. We present two cases of cerebral invasive aspergillosis successfully treated in the intensive care unit with combination antifungal therapies and...

  • Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections. Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. // Drugs;2009, Vol. 69 Issue 3, p361 

    Liposomal amphotericin B (AmBisome®) is a lipid-associated formulation of the broad-spectrum polyene antifungal agent amphotericin B. It is active against clinically relevant yeasts and moulds, including Candida spp., Aspergillus spp. and filamentous moulds such as Zygomycetes, and is...

  • Amphotericin B/amphotericin B liposomal.  // Reactions Weekly;Oct2015, Vol. 1572 Issue 1, p24 

    The article presents a case study of a 49-year-old female patient who developed nephrotoxicity during treatment with amphotericin B and amphotericin B liposomal.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics